Hyperfine (HYPR) Change in Accured Expenses (2021 - 2026)
Hyperfine posted quarterly Change in Accured Expenses of -$1.7 million for Q1 2026, down 16.17% year-on-year from -$2.0 million in Q1 2025, and down 401.45% on a QoQ basis from $553000.0 in Q4 2025.
Hyperfine (HYPR) has 6 years of Change in Accured Expenses data on file, last reported at -$1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 16.17% year-over-year to -$1.7 million; the trailing twelve-month figure through Mar 2026 stood at $100000.0 (up 113.77% YoY), and the FY2025 full-year result was $332000.0, up 148.61% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$1.7 million, down from $553000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.8 million in Q3 2022 and bottomed at -$3.0 million in Q4 2022.
- The 5-year median for Change in Accured Expenses is $18000.0 (2023), against an average of -$288588.2.
- Peak annual rise in Change in Accured Expenses reached 2566.67% in 2024, while the deepest fall reached 4900.0% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at -$3.0 million in 2022, then surged by 101.14% to $34000.0 in 2023, then plunged by 4900.0% to -$1.6 million in 2024, then jumped by 133.88% to $553000.0 in 2025, then slumped by 401.45% to -$1.7 million in 2026.
- The last three Change in Accured Expenses figures came in at -$1.7 million (Q1 2026), $553000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | -1.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.67 Mn |
| Mar 31, 2026 | -1.67 Mn |
| Dec 31, 2025 | 553,000.00 |
| Dec 31, 2025 | 553,000.00 |
| Sep 30, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | -1.44 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | -1.63 Mn |
| Dec 31, 2024 | -1.63 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 480,000.00 |
| Mar 31, 2024 | -1.39 Mn |
| Mar 31, 2024 | -1.39 Mn |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 1.04 Mn |
| Sep 30, 2023 | 1.04 Mn |
| Jun 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 18,000.00 |
| Mar 31, 2023 | -1.84 Mn |
| Mar 31, 2023 | -1.84 Mn |
| Dec 31, 2022 | -2.97 Mn |
| Dec 31, 2022 | -2.97 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Jun 30, 2022 | -507,000.00 |
| Jun 30, 2022 | -507,000.00 |
| Mar 31, 2022 | -1.51 Mn |
| Mar 31, 2022 | -1.51 Mn |
| Dec 31, 2021 | 4.82 Mn |
| Dec 31, 2021 | 4.82 Mn |
| Sep 30, 2021 | 1.49 Mn |
| Sep 30, 2021 | 1.49 Mn |
| Jun 30, 2021 | 843,000.00 |
| Jun 30, 2021 | 843,000.00 |
| Mar 31, 2021 | -307,000.00 |
| Mar 31, 2021 | -307,000.00 |